CEN Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CEN Biotech's past years’ income statements indicate that its last revenue has increased compared to the previous period by 57% to $987,112. The net income raised on -$1,512,666 and profit margin reached -153%. Total operating expenses were $2,251,949.

Profit Margin

CEN Biotech, Inc. (OTC:CENBF): Profit margin
2014 0 -3.16M
2015 0 -2.40M
2016 2.32K -7.58M -326670.75%
2017 0 -14.08M
2018 0 -7.53M
2019 0 -9.25M
2020 0 -9.94M
2021 626.86K -18.90M -3015.58%
2022 987.11K -1.51M -153.24%

CENBF Income Statement (2014 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
987.11K626.86K00002.32K00
Cost of revenue
489.11K02.54M2.57M4.37M11.61M000
Gross profit
498.00K626.86K-2.54M-2.57M-4.37M-11.61M2.32K00
Operating exp.
Research and development
0000032K00643.5K
Selling and marketing
000000000
Total operating expenses
2.25M18.33M2.20M2.57M3.10M11.61M1.10M1.16M3.01M
Operating income
-1.26M-19.03M18.31M-2.57M-4.37M-11.61M-5.98M-1.04M-3.01M
Other income (expenses), net
-249.99K97.52K16.45M-3.07M-1.56M-2.46M-4.88M-1.36M-150.17K
Income before tax
-1.51M-18.94M14.24M-5.65M-7.53M-14.08M-7.58M-2.40M-3.16M
Income tax expense
-2.16K-36.35K24.19M3.59M-288.64K2.37M1.60M1.48M-2.87M
Net income
-1.51M-18.90M-9.94M-9.25M-7.53M-14.08M-7.58M-2.40M-3.16M
Earnings per share
Basic EPS
-0.02-0.45-0.36-0.35-0.3-1.68-0.92-0.34-12.68
Diluted EPS
-0.02-0.45-0.3-0.35-0.3-1.68-0.92-0.34-12.68
Data sourceData sourceData sourceData sourceData sourceData sourceData source